COVID-19 Vaccine Injuries: CICP Claims, PREP Act, and Payouts

If you were injured by a COVID-19 vaccine in the United States, compensation runs through a single federal channel: the Countermeasures Injury Compensation Program (CICP), administered by the Health Resources and Services Administration. You cannot sue the manufacturer in most cases, and you cannot use the better-known “vaccine court” that handles childhood vaccine claims. The CICP has its own deadlines, its own evidentiary standard, and a track record of paying fewer than one percent of COVID-19 claims it has decided.1HRSA. CICP Data

Why COVID-19 Claims Go to the CICP, Not the Vaccine Court

COVID-19 vaccines were authorized under the Public Readiness and Emergency Preparedness (PREP) Act, a 2005 federal law that shields manufacturers, distributors, and administering providers from lawsuits during a declared public health emergency. Courts are required to dismiss claims for death, injury, fear of injury, and property damage related to a covered countermeasure, and the PREP Act expressly preempts state law.2HHS ASPR. PREP Act Questions and Answers In December 2024, HHS extended those liability protections for certain COVID-19 countermeasure activities through 2029, regardless of when the federal public health emergency ends.3American Hospital Association. Certain PREP Act Liability Protections for COVID-19 Countermeasures Extended Through 2029

Because the PREP Act applies, COVID-19 vaccine injuries do not go to the Vaccine Injury Compensation Program (VICP), the judicial “vaccine court” that handles claims for routine childhood vaccines. They go to the CICP instead, and the two programs are not comparable. The VICP uses special masters in the U.S. Court of Federal Claims, works on a preponderance-of-evidence standard, has an injury table that creates presumptive eligibility for listed conditions, and typically covers claimants’ legal fees. Roughly 48 percent of adjudicated VICP petitions have been compensated, with $4.89 billion paid between fiscal years 1989 and 2025.4Kaiser Family Foundation. Federal Vaccine Injury Compensation Programs Overview and Current Issues

The CICP is administrative, not judicial. HHS staff review claims internally, there is no formal court appeal, there is no injury table for COVID-19 vaccines, and every claim gets an individualized scientific review against a higher evidentiary standard. Claimants must prove their “serious physical injury was sustained as the result of the use of a covered countermeasure.” Legal fees are not paid, and the filing window is one year from vaccination, compared with three years under the VICP.4Kaiser Family Foundation. Federal Vaccine Injury Compensation Programs Overview and Current Issues5HRSA. Countermeasures Injury Compensation Program

How to File a CICP Claim

You file directly with HRSA. The core requirements are strict, and most denials to date have turned on them.

The one-year deadline. A claim must be filed within one year of the date the covered countermeasure was administered. Missed deadlines are one of the largest single reasons claims are rejected: of 6,732 denied COVID-19 claims, roughly 2,576 were denied for missing the filing window.1HRSA. CICP Data

The medical records burden. Claimants must gather and submit their own medical records. The CICP does not contact treating providers on your behalf, and you bear the cost of obtaining the documentation. Another 2,576 of the denied COVID-19 claims were rejected for missing medical records.1HRSA. CICP Data5HRSA. Countermeasures Injury Compensation Program

The evidentiary standard. Without an injury table, you must show through compelling, reliable, valid medical and scientific evidence that the vaccine directly caused your injury. About 1,319 denied claims failed at this step.1HRSA. CICP Data

No attorneys’ fees. If you hire a lawyer, you pay them out of any award. The VICP pays reasonable attorneys’ fees separately; the CICP does not.4Kaiser Family Foundation. Federal Vaccine Injury Compensation Programs Overview and Current Issues

Payer of last resort. The CICP only covers expenses not paid by insurance or other third-party sources. Eleven claimants who were found eligible received no compensation because they had no uncovered expenses.1HRSA. CICP Data

What the CICP Has Actually Paid

The numbers set realistic expectations. As of March 2026, the CICP had received 14,129 COVID-19 vaccine injury claims. Of the 6,827 that had reached a decision, only 95 were found eligible for compensation — less than one percent.1HRSA. CICP Data

Across all covered countermeasures (including but not limited to COVID-19), the program had paid more than $13 million to 81 claimants through early 2026. The awards skewed small. Roughly 74 percent were under $10,000, and 14 percent exceeded $100,000. The largest single payment, $5.9 million, went to a claimant who developed thrombosis with thrombocytopenia syndrome after a COVID-19 vaccine.4Kaiser Family Foundation. Federal Vaccine Injury Compensation Programs Overview and Current Issues6HRSA. CICP Compensation Data

Which COVID-19 Vaccine Injuries the CICP Has Compensated

Compensation has been paid for the injury types with the clearest scientific link to COVID-19 vaccination:6HRSA. CICP Compensation Data

  • Myocarditis and pericarditis, most commonly reported after mRNA vaccines (Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax), with the highest risk in adolescent boys and young men within one to four days after the second dose7CDC. COVID-19 Vaccine Information Statement
  • Thrombosis with thrombocytopenia syndrome (TTS), also called vaccine-induced immune thrombotic thrombocytopenia (VITT), linked primarily to the Johnson & Johnson/Janssen and AstraZeneca adenoviral vector vaccines, typically appearing 4 to 42 days after the first dose8American Society of Hematology. Vaccine-Induced Immune Thrombotic Thrombocytopenia
  • Guillain-Barré syndrome, tied by CDC surveillance to the Janssen vaccine but not to the mRNA vaccines, with symptom onset averaging about five days after vaccination9CDC. Guillain-Barré Syndrome and Vaccines
  • Anaphylaxis, estimated at about 5 cases per million doses, generally within minutes of injection10CDC. COVID-19 Vaccine Safety
  • Shoulder injuries related to vaccine administration6HRSA. CICP Compensation Data

One boundary worth flagging: some patients report chronic, debilitating symptoms — fatigue, brain fog, neuropathy, palpitations, dizziness — beginning shortly after vaccination and persisting for months or years. Researchers at Yale have called this “post-vaccination syndrome” (PVS) and are studying it, but it has no official medical diagnosis code and is not formally recognized by regulatory agencies.11STAT News. Yale Post-Vaccination Syndrome Participants in LISTEN Study Want Answers, Not Politics12CDC ACIP. ACIP COVID-19 Presentation Without a recognized causal link, claims resting on these symptoms alone face the highest hurdle at the CICP’s evidentiary review.

Why So Few Claims Succeed

The CICP was not designed to handle mass-vaccination-scale claim volumes. It faces staffing shortages, long review times, and thousands of pending claims. HRSA has acknowledged that many pending claims are stalled while the agency waits for medical records and documentation the claimant is responsible for producing.5HRSA. Countermeasures Injury Compensation Program

Structural features compound the volume problem. There is no injury table for COVID-19 vaccines, so there is no presumption of causation even for conditions the FDA and CDC formally recognize as vaccine-linked. The one-year filing deadline is shorter than most claimants realize, and by the time an injury is diagnosed and worked up, the window may have closed. Legal fees come out of any award, which limits access to experienced counsel. Legal experts, lawmakers, and patient advocates have argued the program is structurally hostile to claimants, pointing to the sub-one-percent COVID-19 compensation rate against the VICP’s roughly 48 percent.4Kaiser Family Foundation. Federal Vaccine Injury Compensation Programs Overview and Current Issues

Suing the Manufacturer: The PREP Act Bar

Under the PREP Act, product liability suits against COVID-19 vaccine manufacturers are foreclosed in nearly all circumstances. The only exception is “willful misconduct” — an intentional act taken to achieve a wrongful purpose, knowingly without justification, and in disregard of an obvious risk. A plaintiff must prove it by clear and convincing evidence, a higher bar than ordinary negligence.2HHS ASPR. PREP Act Questions and Answers

The procedural hurdles for a willful-misconduct suit are unusual. The case can only be filed in the U.S. District Court for the District of Columbia, must be heard by a three-judge panel, and, for a claim against a manufacturer, requires a prior successful enforcement action by the U.S. Attorney General or the FDA.2HHS ASPR. PREP Act Questions and Answers In practice, that standard has proved essentially insurmountable for individual claimants.

The picture looks different outside the United States. In the United Kingdom, roughly 50 individuals and families who suffered VITT after AstraZeneca vaccination have brought a product liability claim under the Consumer Protection Act 1987, arguing the vaccine was “defective” and not as safe as recipients were entitled to expect. AstraZeneca has accepted in court documents that its vaccine can, in rare cases, cause TTS. The UK government indemnified AstraZeneca during the pandemic and is effectively funding the defense. The case was expected to reach trial in 2025 or 2026.13Leigh Day. AstraZeneca COVID-19 Vaccine Claim The UK also runs a separate Vaccine Damage Payment Scheme, which caps compensation at £120,000, a figure unchanged since 2010; claimants are pressing the UK’s COVID-19 Public Inquiry to recommend reform.14Leigh Day. Those Seriously Injured or Bereaved as a Result of COVID-19 Vaccine Hope Upcoming Report Will Trigger Long-Awaited Reform of Vaccine Compensation Scheme Neither route is available to U.S. claimants.

Reform Efforts and Political Turbulence

The most direct legislative fix would move COVID-19 vaccines out of the CICP and into the VICP. In August 2023, Representatives Lloyd Doggett and Lloyd Smucker introduced the Vaccine Injury Compensation Modernization Act, which would have transferred pending COVID-19 claims to the VICP, raised the ceiling on special masters from 8 to a floor of 10, increased the statutory $250,000 cap on pain-and-suffering damages (unchanged since 1988) to account for inflation, and extended the filing deadline from three to five years.15Rep. Lloyd Doggett. Rep. Doggett Files Legislation to Modernize Vaccine Injury Compensation Program The bill did not advance, and no similar legislation has passed.4Kaiser Family Foundation. Federal Vaccine Injury Compensation Programs Overview and Current Issues

The politics have grown more volatile under HHS Secretary Robert F. Kennedy Jr. In July 2025, Kennedy called the VICP “a morass of inefficiency, favoritism, and outright corruption” and said he was working with the Department of Justice to overhaul it. He has also argued that COVID-19 vaccine claims should be moved into the VICP.16CNN. Vaccine Injury Compensation Program RFK In June 2025, he appointed Drew Downing, a vaccine court litigator, to oversee changes to the program.17U.S. Senator Elizabeth Warren. Warren, Blumenthal, Markey, Alsobrooks Press RFK Jr. on Dangerous Backdoor Overhaul of Vaccine Court In January 2026, Kennedy fired at least half the members of the Advisory Commission on Childhood Vaccines, which advises on the VICP, without naming replacements.18STAT News. Kennedy Fires Vaccine Injury Compensation Advisers A group of U.S. Senators accused him of a “backdoor overhaul” of the vaccine court and warned that adding conditions to the VICP injury table without an established scientific link could undermine the program’s credibility and finances.

For anyone with a current injury, none of this changes the rules today. Claims are still filed with the CICP, still subject to the one-year deadline, and still evaluated under the case-by-case scientific standard the program applies now. If you believe you have a claim, the practical priorities are the deadline, complete medical records tying the injury to the vaccination, and documentation of expenses insurance has not paid.